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Abstract
Background Kidney diseases are a recognized cause of posterior reversible leukoencephalopathy syndrome, usually abbre-
viated as PRES. The purpose of this review was to systematically address the association between acute postinfectious 
glomerulonephritis and PRES.
Methods We performed a systematic review of the literature on acute postinfectious glomerulonephritis associated with 
PRES. The principles recommended by the Economic and Social Research Council guidance on the conduct of narrative 
synthesis and on the Preferred Reporting Items for Systematic Reviews and Meta-analyses were used. Databases searched 
included Excerpta Medica, US National Library of Medicine, and Web of Science.
Results For the final analysis, we evaluated 47 reports describing 52 cases (32 males and 20 females). Fifty patients 
were ≤ 18 years of age. Blood pressure was classified as follows: normal-elevated (n = 3), stage 1 hypertension (n = 3), stage 
2 hypertension (n = 5), and severe hypertension (n = 41). Acute kidney injury was classified as stage 1 in 32, stage 2 in 16, 
and stage 3 in four cases. Neuroimaging studies disclosed a classic posterior PRES pattern in 28 cases, a diffuse PRES pattern 
in 23 cases, and a brainstem-cerebellum PRES pattern in the remaining case. Antihypertensive drugs were prescribed in all 
cases and antiepileptic drugs in cases presenting with seizures. A resolution of clinical findings and neuroimaging lesions 
was documented in all cases with information about follow-up.
Conclusions The main factor associated with PRES in acute postinfectious glomerulonephritis is severe hypertension. Prompt 
clinical suspicion, rapid evaluation, and management of hypertension are crucial.
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Posterior reversible leukoencephalopathy syndrome, usu-
ally abbreviated as PRES, is a rather uncommon condition, 
whose diagnosis relies both on clinical and imaging fea-
tures [1, 2]. The clinical presentation includes headache or 
nausea; altered mental status; seizures; visual perception 
abnormalities; and, less frequently, further focal neurologic 
signs. Neuroimaging studies demonstrate a characteristically 
reversible vasogenic edema that generally involves the sub-
cortical white matter in the posterior cerebral regions [2]. 
A variety of conditions have been implicated as causes of 
PRES, including among others severe arterial hypertension 
and both acute and chronic kidney diseases [2]. Some drugs 
have also been deemed to cause PRES [3].
Stimulated by our past experience [4, 5], we report here 
the first systematic literature review on PRES in postinfec-
tious (poststreptococcal) glomerulonephritis, the prototypi-
cal and most widely known acute glomerulonephritis syn-
drome [6, 7]. The objectives were to document features, 
associated factors, neuroimaging data, and clinical course.
Methods
Literature search strategy
For this analysis, we followed the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses guidelines and 
searched up to November 2020 in the US National Library of 
Medicine, Excerpta Medica, and Web of Sciences databases 
[8]. We carried out a structured literature search without 
date limitation using the Medical Subject Headings terms 
“poststreptococcal glomerulonephritis” OR “postinfectious 
glomerulonephritis” AND “encephalopathy” OR “posterior 
reversible encephalopathy syndrome” OR “posterior reversi-
ble leukoencephalopathy syndrome” OR “PRES.” Articles in 
languages other than Spanish, Portuguese, Italian, German, 
French, English, or Dutch were not included. The literature 
search was carried out by two investigators (CO, MGB), who 
independently screened the title and abstract of all reports in 
a non-blinded fashion to include pertinent reports. Discrep-
ancies in study identification were resolved by consensus. 
Subsequently, full-text publications were reviewed to decide 
whether the presented case fit the eligibility criteria of the 
review. Personal files and the bibliography of each identified 
report were also screened for further references. Institutional 
Review Board approval was not required for this literature 
review.
Selection criteria—definitions—data extraction
Of interest were subjects without any pre-existing kidney or 
cerebral disease presenting with acute postinfectious glo-
merulonephritis and PRES, whose history had been pub-
lished in full-length articles or letters. Prospectively defined 
criteria were used to confirm or infirm the diagnosis of acute 
poststreptococcal glomerulonephritis, arterial hypertension, 
and PRES made in the original articles.
The diagnosis of postinfectious glomerulonephritis 
was retained in patients with acute onset of hematuria and 
proteinuria associated with (a)  C3 hypocomplementemia 
returning to normal within 16 weeks, (b) increasing anti-
streptoscorecoccal antibodies, or (c) distinctive kidney 
biopsy findings [6, 7]. The KDIGO criteria [9] were used 
to classify acute kidney damage as stage 1 (increase in cre-
atinine to 1.5–1.9 times baseline or increase by ≥ 27 μmol/l 
above the upper limit of normal for age), stage 2 (increase 
in creatinine to 2.0–2.9 times baseline), or stage 3 (increase 
in creatinine to ≥ 3.0 times baseline, increase in creatinine 
by ≥ 354 μmol/l, or initiation of dialysis).
The highest recorded blood pressure value at presentation 
was used to categorize hypertension as stage 1 (subjects 1 
to < 13 years of age with blood pressure readings ≥ 95th per-
centile to 95th percentile + 12 mm Hg; subjects ≥ 13 years 
with readings between 130/80 and 139/89 mm Hg); stage 2 
(subjects 1 to < 13 years of age with readings 95th percen-
tile + 12 mm Hg to 95th percentile + 30 mm Hg; subjects 
aged ≥ 13 years with reading ≥ 140/90 to 179/119 mm Hg); 
or severe (subjects 1 to < 13 years of age with readings ≥ 95th 
percentile +  > 30 mm Hg; subjects aged ≥ 13 years with 
readings > 180/120 mm Hg). Blood pressure was categorized 
as normal in the remaining cases [10, 11].
The diagnosis of PRES was made on the basis of both an 
acute onset of at least one of five neurologic features ((1) 
headache or nausea; (2) altered mental status; (3) seizures; 
(4) visual perception abnormalities; (5) further focal neuro-
logic signs) and distinctive neuroimaging findings [12, 13].
Neuroimaging data were classified based on lesion loca-
tion patterns and severity. Lesion location patterns were cat-
egorized based on cerebral edema distribution (Fig. 1) as 
posterior, anterior, diffuse, brainstem-cerebellum, or basal 
ganglia [12]. Lesion severity was categorized as mild, mod-
erate, or severe according to the vasogenic edema extent, 
the involvement of deep structures (cerebellum, brainstem, 
or basal ganglia), and the presence of parenchymal hemor-
rhage [13].
In addition to demographics, from each reported case, we 
evaluated the following clinical information: non-renal and 
non-cerebral pre-existing conditions, initial presentation, the 
abovementioned neurologic findings, blood pressure values, 
laboratory data (including creatinine among others), patient 
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management, and the disease course. The following neuro-
imaging data were weighted: brain scans performed with 
magnetic resonance imaging (MRI) rather than computed 
tomography (CT), accuracy of technical report, description 
of distribution patterns, figure and caption preciseness.
Two authors graded subjectively in consensus the com-
prehensiveness in reporting the clinical (CO, MGB) and the 
neuroimaging data (RW, MCL) as satisfactory or good.
Analysis
A pilot-tested form was used for data extraction and record-
ing. Results are given as median and interquartile range or 
as frequency, as appropriate. The Wilcoxon rank-sum test 
was used to compare continuous variables and the Fisher 
exact test to compare dichotomous variables. Significance 
was assigned at P < 0.05.
Results
Search outputs
The study flowchart is shown in Fig. 2. For the final analysis, 
we retained 47 scientific reports [4, 5, 14–58] detailing 52 
original cases published since 1993: 22 from Asia (Turkey, 
n = 8; India, n = 7; Japan, n = 3; Pakistan, n = 1; Saudi Ara-
bia, n = 1; Sri Lanka, n = 1, Taiwan, n = 1), nine from Europe 
(Germany, n = 2; Italy, n = 2; Belgium, n = 1; Greece, n = 1; 
Netherlands, n = 1; Spain, n = 1; Switzerland, n = 1), eight 
from North America (USA, n = 7; Canada, n = 1), six from 
South America (Argentina, n = 2; Brazil, n = 1; Colombia, 
n = 1; Trinidad, n = 1; Uruguay, n = 1), and two from Africa 
(Morocco, n = 1; Tunisia, n = 1). Thirty-eight articles were 
published in English, five in Spanish, two in French, one in 
Dutch, and one in German.
The comprehensiveness in reporting clinical data was 
good in 44 and satisfactory in eight cases, that is, report-
ing neuroimaging data was good in 31 and satisfactory in 
21 cases.
Clinical and laboratory data at presentation
Information on the 52 patients – 50 children and 2 
adults – appears in Table 1. The initial clinical presentation was 
neurologic in three quarters of the cases. Seizures, headache, 
nausea, altered mental status, and visual disturbances were, in 
decreasing order of frequency, the main neurologic features. 
Arterial hypertension was severe in approximately 80% of 
cases. Stage 3 acute kidney injury was noted in less than 10% 
of cases.
The following neuroimaging techniques were used for 
the evaluation of disease onset in the 52 patients: MRI 
Fig. 1  Posterior reversible 
leukoencephalopathy syndrome. 
Sketch depicting the five lesion 
location patterns of white 
matter edema (blue): posterior, 
anterior, diffuse, brainstem-





(n = 24); CT followed by MRI (n = 22); CT (n = 6). A CT 
with a contrast agent was obtained in four cases. An inva-
sive digital subtraction angiography study was performed 
in two cases [17, 27]. The following magnetic resonance 
imaging sequences were used in the 46 patients: T2WI and/
or FLAIR, n = 46; DWI with ADC, n = 20; TOF, n = 3; T1 
C + , n = 7. A posterior pattern of distribution was detected 
in 28 cases, a diffuse pattern in 23 cases, and a brainstem-
cerebellum-predominant pattern in the remaining case [14]. 
No patient was found to have an anterior or a basal ganglia 
pattern. The neuroimaging severity score was mild in about 
95% of cases.
Further neuroimaging abnormalities were observed in 
three cases [32, 33, 56], as shown in Table 2. Two of the 
mentioned children were concurrently affected by sickle 
cell anemia [33, 56]. The 9-year-old girl reported by Hanafy 
[56] concomitantly presented with an acute postinfectious 
glomerulonephritis and a vaso-occlusive crisis. No features 
consistent with a vaso-occlusive crisis were noted in the 
10-year-old boy reported by Pashankar [33].
No significant statistical difference was noted between 
patients with a posterior pattern and patients with a diffuse 
pattern with respect to demographics, initial clinical presen-
tation, neurologic features (including visual disturbances), 
blood pressure, kidney injury, and neuroimaging severity 
score (Table 1).
Patients with severe arterial hypertension and patients 
with normal or non-severe hypertension did not significantly 
differ with respect to gender, age, neurologic features, sever-
ity of acute kidney injury, and edema distribution pattern 
(Table 3). Antihypertensive drugs were more frequently 
prescribed in the group of patients with severe hypertension.
Management course
Drug management is depicted in Table 1. Noticing that anti-
hypertensive and antiepileptic drug therapy was adminis-
tered in a heterogeneous manner, was frequently adjusted, 
and was often poorly documented in the articles, no attempt 
was made to condense these data. Eleven patients received 
systemic corticosteroids.
A full resolution of clinical findings including among oth-
ers the neurologic examination, blood pressure, urinalysis, 
and kidney function was documented within 3 to 16 weeks 
in 47 cases, including the three children found to have either 
an ischemic or a hemorrhagic brain lesion [32, 33, 56].
Follow-up neuroimaging studies were performed in 38 
cases [2–8] 4 weeks after disease onset: MRI in 33 cases 
(including one patient revalued also by a digital subtraction 
angiography) and CT in 5 cases. A complete resolution of 
the lesions was noted in all of them, including the aforemen-
tioned three cases complicated by ischemic or hemorrhagic 
lesions [32, 33, 56].
Discussion
This is the first systematic review to investigate the associa-
tion of acute postinfectious glomerulonephritis with PRES. 
The results indicate that this association predominantly 
affects, like glomerulonephritis without encephalopathy 
[6, 7], male school-aged children, that it is associated with 
severe arterial hypertension in four out of five cases and its 
prognosis is generally favorable.
It has been suggested that severe acute-onset arterial 
hypertension accounts for most cases of PRES [1, 2]. In 
our survey, blood pressure was severely elevated in approx-
imately 80% of cases, thereby supporting the abovemen-
tioned link. The term hypertensive encephalopathy was tra-
ditionally used to denote this important form of PRES [2, 
59, 60]. Since cerebral blood flow is normally maintained 
at a constant level by vascular resistance autoregulation, 
PRES likely occurs in cases with blood pressure beyond the 
upper autoregulation limit. In this setting, a breakdown of 
the blood–brain barrier allows for the extravasation of blood 
Full-text articles included (n = 47)
Records excluded (n = 57)
- Not pertaining (n=33)
- Not containing human cases (n = 10)
- No original cases (n = 11)
- Abstracts (n = 3)
Records screened after duplicates removed (n = 117)
Full text accessed in detail for eligibility (n=60)
Records identified










through search in 
the Web of Science
Database
(n = 34)
Records excluded (n = 15)
- Narrative reports (n = 2)
- Pre-existing kidney disease (n = 3)
- No original or human cases (n = 4)
- Inclusion criteria not fulfilled (n = 6*)
Secondary references (n = 1)
Personal files (n = 1)
Fig. 2  Posterior reversible leukoencephalopathy syndrome associated 
with acute postinfectious glomerulonephritis. Flowchart of the litera-
ture search process (*poor-quality neuroimaging studies, n = 5; poorly 
documented kidney disease, n = 1)
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Table 1  Clinical, laboratory, 
and imaging data in 52 patients 
from 7 to 32 years of age 
with acute poststreptococcal 
glomerulonephritis associated 
with posterior reversible 
leukoencephalopathy syndrome. 
Data are given as median 
(with interquartile range) or 
as relative frequency (with 
percentage)
* Posterior versus diffuse
All Posterior Diffuse Brainstem 
cerebellum
P-value*
N 52 28 23 1
Males:females, N 32:20 18:10 14:9 0:1  > 0.999
Age
 Years 11 [9–13] 10 [9–12] 12 [10–14] 9 0.121
 ≤ 18 years, N (%) 50 (96) 26 (93) 23 (100) 1 0.494
Pre-existing condition, N (%) 2* (4) 0 (0) 2* (9) 0 0.492
Initial presentation
  Neurologic, N (%) 37 (71) 21 (75) 16 (70) 0 0.757
  Renal, N (%) 13 (25) 5 (18) 7 (30) 1 0.336
  Neurologic and renal, N (%) 2 (4) 2 (7) 0 (0) 0 0.495
Neurologic features
  Headache-nausea, N (%) 44 (85) 25 (89) 19 (83) 1 0.687
  Altered mental status, N (%) 38 (73) 20 (71) 18 (78) 0 0.749
  Seizures, N (%) 46 (88) 23 (82) 22 (96) 1 0.739
  Visual abnormalities, N (%) 29 (56) 17 (61) 11 (48) 1 0.407
  Further focal signs, N (%) 13 (25) 5 (18) 8 (35) 0 0.207
Blood pressure
  Normal-elevated, N (%) 3 (6) 0 (0) 3 (13) 0 0.085
  Stage 1 hypertension, N (%) 3 (6) 0 (0) 2 (9) 1 0.198
  Stage 2 hypertension, N (%) 5 (10) 4 (4) 1 (4) 0 0.362
  Severe hypertension, N (%) 41 (79) 24 (86) 17 (74) 0 0.316
Acute kidney injury
  Stage 1, N (%) 32 (62) 19 (68) 13 (57) 0 0.561
  Stage 2, N (%) 16 (31) 8 (29) 8 (35) 0 0.369
  Stage 3, N (%) 4 (8) 1 (4) 2 (9) 1 0.583
Neuroimaging severity score
  Mild, N (%) 49 (94) 28 (100) 21 (91) 0 0.198
  Moderate, N (%) 2 (4) 0 (0) 1 (4) 1 0.451
  Severe, N (%) 1 (2) 0 (0) 1 (4) 0 0.451
Drug therapy
  Antihypertensives, N (%) 48 (92) 27 (96) 21 (91) 0 0.583
  Antiepileptics, N (%) 38 (73) 19 (68) 19 (83) 0 0.336
  Corticosteroids, N (%) 11 (21) 3 (21) 7 (13) 1 0.154
Table 2  Neuroimaging abnormalities other than vasogenic edema in 3 patients with PRES associated with acute poststreptococcal glomerulone-
phritis [32, 33, 56]
Gender Female [56] Male [33] Female [32]
Age, years 9 10 13
Concomitant condition Sickle cell disease with vaso-occlusive crisis Sickle cell disease without 
vaso-occlusive crisis
None
Neuroimaging PRES pattern Diffuse Diffuse Diffuse
Blood pressure Stage 3 hypertension Stage 3 hypertension Normal-elevated
Abnormality Ischemic lesions involving the cortex of the right 








products and extracellular vasogenic edema, which mainly 
affects the white matter via leakage of fluid from capillaries 
[59, 60]. Blood pressure was normal or not severely elevated 
in approximately 20% of cases included in this analysis [59, 
60]. The present figures differ from those observed in immu-
noglobulin A vasculitis [61]. In the latter condition, PRES 
was associated with severe hypertension in no more than 
every third case, suggesting a crucial pathogenic role for 
the cerebral vasculitis in the majority of cases [61]. It is 
therefore tempting to assume that, like in immunoglobulin A 
vasculitis associated with PRES [61], an infectious precursor 
may concurrently trigger both a glomerulonephritis and a 
cerebral vascular dysfunction [14]. Agents such as calcineu-
rin inhibitors; sirolimus; platinum-containing cancer drugs; 
angiogenesis inhibitors; and, more rarely, systemic corticos-
teroids have also been associated with PRES [3] but none of 
the patients included in this review were pretreated with the 
mentioned agents. Very recent data argue for a central role 
of innate in the pathophysiology of PRES [62].
The term PRES was adopted 25 years ago [1] because 
neuroimaging studies detected a brain edema situated in 
the subcortical white matter of the occipital region. This 
edema pattern was noted in slightly more than half of our 
cases. In this study, however, we observed a diffuse edema in 
more than 40% of cases, as reported in the recent literature 
[2, 12, 13]. It has been therefore suggested to abandon the 
word “posterior” and use instead terms such as reversible 
leukoencephalopathy syndrome or acute brain capillary 
leak syndrome [2]. Interestingly, demographics, the clini-
cal features, and the severity of arterial hypertension and 
kidney disease did not differ between patients with poste-
rior and diffuse brain edema. Intracranial hemorrhage and 
ischemia may occur in a minority of patients with PRES, as 
confirmed by the present analysis [2]. Remarkably, two of 
the three patients with the aforementioned complications 
of PRES were affected by sickle cell anemia. Since PRES 
is being increasingly recognized in sickle cell anemia [63], 
we tentatively speculate that both acute glomerulonephritis 
and sickle cell anemia might have contributed to the devel-
opment of PRES.
The present data do not allow us to suggest the manage-
ment of PRES in acute postinfectious glomerulonephritis. 
However, it is assumed but not proven that early recognition 
and treatment are of paramount importance because PRES 
is usually reversible with appropriate management [2, 59, 
60, 64]. Neuroimaging is essential to the diagnosis. While 
a brain CT scan is sometimes the first study performed, a 
brain magnetic resonance imaging with an imaging protocol 
tailored to PRES is the critical imaging method [65].
Table 3  Characteristics of 
patients with severe arterial 
hypertension and patients 
with normal or non-severe 
hypertension. Data are 
presented as median (with 





Normal or non-severe 
hypertension
N 41 11
Males:females, N 25:16 7:4  > 0.999
Age, years 11 [9–13] 12 [10–14] 0.208
Neurologic features
  Headache-nausea, N (%) 35 (85) 9 (82)  > 0.999
  Altered mental status, N (%) 29 (71) 9 (82) 0.469
  Seizures, N (%) 37 (90) 9 (82) 0.595
  Visual abnormalities, N (%) 22 (54) 7 (64) 0.735
  Further focal signs, N (%) 12 (29) 1 (9.1) 0.253
Acute kidney injury
  Stage 1, N (%) 25 (61) 7 (64)  > 0.999
  Stage 2, N (%) 14 (34) 2 (18) 0.468
  Stage 3, N (%) 2 (4.9) 2 (18) 0.193
Edema distribution pattern
  Posterior, N (%) 24 (58) 4 (36) 0.308
  Diffuse, N (%) 17 (41) 6 (55) 0.507
  Brainstem-cerebellum, N (%) 0 1 (9.1) 0.212
Drug therapy
  Antihypertensives, N (%) 41 (100) 7 (64)  < 0.005
  Antiepileptics, N (%) 30 (73) 8 (73)  > 0.999
  Corticosteroids, N (%) 9 (22) 2 (18)  > 0.999
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The currently recommended mainstay of therapy is reduc-
tion of excessive blood pressure. With blood pressure low-
ered, most patients improve dramatically [64]. Goal blood 
pressure depends on presenting levels. Like in all cases of 
severe symptomatic acute hypertension, a reduction of mean 
blood pressure by ≤ 20–25% within 6–9 h is often advised 
[63, 64, 66]. However, excessive blood pressure lowering 
might reduce pressure below the autoregulatory range [64, 
66]. Reducing blood pressure is also recommended for lower 
levels of arterial hypertension. In these cases, a reduction 
by 10% within days seems a realistic target [64]. The use 
of easily titratable parenteral agents is effective and safe in 
reducing blood pressure to a desirable range. Systemic cor-
ticosteroids are sometimes prescribed in acute postinfectious 
glomerulonephritis and in PRES [2, 6, 7]. However, this is 
not generally recommended.
There are limitations and strengths that should be con-
sidered when reading the results of this review. The major 
limitation results from the small number of reported cases, 
which were sometimes not very well documented. Second, 
since treatment recommendations can be uneasily inferred 
by pooling individual cases, suggested therapy recommen-
dations arise from low-quality evidence. Finally, a system-
atic review addressing all PRES cases associated with an 
acute glomerulonephritis syndrome including among others 
immunoglobulin A vasculitis, immunoglobulin A glomeru-
lonephritis, and classic post-diarrheal hemolytic-uremic 
syndrome might have perhaps allowed for a more in-depth 
data analysis.
The most relevant strength of the study relates to the com-
prehensive and exhaustive literature search, which aimed at 
surveying the entire literature on PRES complicating acute 
postinfectious glomerulonephritis.
Conclusion
Unlike immunoglobulin A vasculitis, severe hypertension is 
the main factor underlying PRES in acute poststreptococcal 
postinfectious glomerulonephritis. The mechanisms under-
lying PRES in the absence of severe hypertension deserve 
future investigations.
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